Subject: Tamoxifen VS Raloxifene For Gyno Treatment
From: PCT.ZONE <[email-masked]>
To: [email-masked]
Date: Fri, 17 Apr 2026 17:45:23 +0000 (GMT)
List-Id: [email-masked]

What is the better option?‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌  ‌ 

Greetings! 

Gynecomastia, the growth of breast tissue in males, is a common side effect of AAS use due to estrogenic activity caused by aromatization or progestogenic compounds. It can be physically and psychologically distressing, so many bodybuilders resort to getting an expensive and invasive surgery to get it fixed. 

However, there are ways to deal with this side-effect without having to go under the knife, and for a fraction of the price. Selective Estrogen Receptor Modulators (SERMs) like Raloxifene and Tamoxifen are commonly used to address this condition, with moderate to absolute success. 

Lets examine the mechanisms, benefits, and drawbacks of both drugs, comparing their efficacy and safety to determine what the better option for managing gynecomastia is! 

WHAT IS TAMOXIFEN? 

Tamoxifen is one of the most well-established SERMs, widely used for treating estrogen-receptor-positive breast cancer and gynecomastia. By competitively inhibiting estrogen binding in breast tissue, tamoxifen effectively prevents and reverses the growth of glandular tissue. It has been associated with side effects such as hot flashes, mood swings, and a slightly increased risk of blood clots. 

Its proven track record makes it a reliable option for treating AAS-induced gynecomastia , but it only seems to work effectively for the treatment of early-stage, recently-developed gynecomastia. 

The typical dose for the treatment of gynecomastia is 20mg a day, although severe cases may require up to 40mg a day, for up to 3 months at a time. GET TAMOXIFEN 

WHAT IS RALOXIFENE? 

Raloxifene is a second-generation SERM primarily used to treat and prevent breast cancer and osteoporosis in postmenopausal women. It works by selectively binding to estrogen receptors, acting as an antagonist in breast tissue while preserving estrogen's beneficial effects in bones and other tissues. It has a favorable side effect profile, with lower risks of thromboembolism and other estrogenic side effects compared to older SERMs. 

Raloxifene has shown strong efficacy in reducing gynecomastia, even in extreme cases where the amount of breast tissue is significant and has existed for extended periods of time. As such, it is effective for both AAS-induced and pubertal gynecomastia. 

It is commonly dosed at 30 to 60mg per day, for up to 3 months at a time. BUY RALOXIFENE HERE! 

WHAT IS THE BETTER OPTION? 

For the prevention of gynecomastia development and in cases where the gynecomastia is mild and recent, Tamoxifen works just fine. Raloxifene is a viable option in those situations as well, but it is especially useful when dealing with advanced gynecomastia that has existed for months or even years. 

Whether you have gynecomastia or not, we recommend stocking up on both medications, as it is always better to have them and not need them, than need them and not have them... 

Looking for a trusted supplier of pharmaceutical-grade medications? Visit the link below to check out our entire catalogue. PCT.ZONE 

© Copyright, 2026, • 

You received this email because you are subscribed to newsletters from . 

Unsubscribe